Dr. Airica Steed's Transformational Leadership at MetroHealth

February 7, 2025 6:05 PM

Dr. Airica Steed's legacy as the CEO of MetroHealth is one defined by progress, innovation, and an unwavering commitment to creating a more equitable healthcare system. Serving as MetroHealth's president and CEO, Dr. Steed brought groundbreaking changes during her tenure, transforming the Cleveland-based health system into a $2 billion powerhouse. Her achievements are a testament to her pioneering vision and dedication to reversing healthcare...

Read more

NHI Announces Retirement of Robert Webb from the Board of Directors

February 7, 2025 5:30 PM

National Health Investors, Inc. (NYSE:NHI) announced today that after more than 34 years of leadership and guidance on the NHI Board of Directors, Robert Webb has notified the Board that he is resigning effective immediately.Robert Webb joined the NHI Board of Directors upon its inception in 1991. Since that time, the Company has grown its diversified healthcare real estate investment and senior housing operating portfolios to over $3.0 billion...

Read more

Roger Kasendorf, DO, Receives 2024 Best of La Jolla Award

February 7, 2025 3:15 PM

Roger Kasendorf, DO, has been selected for the 2024 Best of La Jolla Award in the Physiatrist category by the La Jolla Award Program.Each year, the La Jolla Award Program identifies companies it believes have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small businesses through service to their customers and our community. These exceptional...

Read more

Axene Health Partners Unveils In-Depth Analysis of Healthcare Denial Rates: Fact vs. Fiction

February 7, 2025 11:00 AM

Axene Health Partners (AHP) has released a new thought leadership article, "Denial Rates: Fact or Fiction?", providing a data-driven examination of healthcare claim denials and the myths that often surround them. The article explores industry trends, key factors influencing denial rates, and practical strategies for healthcare stakeholders to improve claims processing and reduce administrative inefficiencies.Denial rates have become a hot topic...

Read more

Tour DaVita's Net-Zero Dialysis Center

February 7, 2025 10:30 AM

Last year, DaVita opened the doors to the first net-zero dialysis center in the U.S. Check out this video to learn more about the center, located outside of Atlanta, GA, to discover the features the team designed to help the center produce as much energy as it consumes.Do you want to learn more about the center? Check out, "DaVita Completes Construction on First Planned Net-Zero Dialysis Center, Expected to Offset Energy Consumption with...

Read more

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

February 7, 2025 10:00 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its wholly owned subsidiary, Cana Laboratories ("Cana"), has entered into a new long-term ten-year contract...

Read more

IRLAB: Invitation to the Year-End Report 2024 Presentation and Webcast

February 7, 2025 5:00 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 7, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will hold a presentation in conjunction with the publication of the year-end report for 2024. The interim report will be published on Wednesday, February 12 at 07:00 CET.The presentation will be held on...

Read more

Q4 and Full Year Report 2024: Completion of Full Study Report Reinforces Successful Outcomes of SPARKLE Phase 3 Study

February 7, 2025 2:00 AM

Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker: ACE) today published its Q4 and Full Year Report for 2024 (January - December), which is now available on the company's website: https://www.ascelia.com/ir-media/financial-reports/KEY EVENTS IN Q4 2024Orviglance SPARKLE study primary results accepted as cutting-edge oral presentation at RSNA 2024Proposal for election of Marianne Kock as new member of the Board of DirectorsNotice of and...

Read more

Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research

February 6, 2025 7:31 PM

Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, Inka Health Corp. ("Inka Health") has entered into an Expression of Interest (EOI) with Quantify Research ("Quantify"), a leading global provider of healthcare data analytics and real-world evidence solutions. This EOI establishes a framework for potential collaboration between the two entities to...

Read more

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

February 6, 2025 3:50 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has received an initial purchase order of $578,460 from Al Rabwa International Services and Trading ("Al Rabwa")...

Read more

Transforming Incontinence Treatment for Children: The Work of Dr. Robert W. Collins

February 6, 2025 3:50 PM

Dr. Robert W. Collins is a retired but highly active clinical psychologist with an advanced degree from Indiana University in Bloomington, IN. With over four decades of experience in child psychology and medical research, Dr. Collins has dedicated his career to tackling the complex and often misunderstood challenges of bladder and bowel incontinence in children. His approach is rooted in rehabilitation rather than short-term solutions, offering...

Read more

CenExel Celebrates FDA Approval of JOURNAVX(TM), a Groundbreaking Non-Opioid Pain Treatment

February 6, 2025 12:00 PM

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals' clinical studies that led to the FDA approval of JOURNAVX™ (suzetrigine), the first-in-class, non-opioid oral pain signal inhibitor for adults with moderate-to-severe acute pain. This landmark approval marks the first new class of pain medicine in over 20 years, offering patients an effective and...

Read more

Smile Digital Health Secures $15 Million in Credit Financing With FirePower Capital to Accelerate Growth and Innovation in Health Data Solutions

February 6, 2025 10:30 AM

Smile CDR Inc. (d.b.a. Smile Digital Health), the world leader in FHIR®-based health data solutions, today announced a successful $15 million credit financing agreement with FirePower Capital. This strategic partnership will enable Smile to accelerate the growth and development of its market-leading health data platform and further expand its innovative solutions for the healthcare sector.As the leading solution provider in the U.S. payer...

Read more

Leinco Technologies Awarded $1M Grant to Develop Rapid Test for Intestinal Immunity to Polio

February 6, 2025 10:00 AM

Leinco Technologies, a leader in antibody and protein development, is thrilled to announce that it has been awarded a $1M grant from the Gates Foundation. The grant aims to develop a rapid field assay (lateral flow or similar) to assess the intestinal immune response to poliovirus, potentially enabling efficient monitoring of vaccination campaigns and rapid identification of polio-exposed communities. The availability of such a test could...

Read more

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference

February 6, 2025 10:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Dr. Karen Brunke, Jaguar's EVP of Corporate and Business Development and Acting CEO of Magdalena Biosciences, Inc. (Magdalena), the joint venture formed by Jaguar and Filament Health Corp. (OTCQB:FLHLF) (CBOE CA:FH) (FSE:7QS) to develop novel, natural prescription medicines derived from plants for mental health indications, is presenting in person on Monday, February 10, 2025 at 2:30 PM...

Read more

Innovation Zed and Glooko Partner to Revolutionize Injectable Therapy Management with Digital Companion Apps

February 6, 2025 9:30 AM

Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, and Innovation Zed, a pioneering developer of connected add-on devices for drug delivery devices, today announced a strategic partnership to develop and deploy digital companion apps with the adaptive DOSE platform hardware add-on technology for injectable therapies. This collaboration aims to revolutionize the...

Read more

Clarity Clinic Expands PHP/IOP Mental Health Programs to Evanston, Providing Greater Access to Care

February 6, 2025 9:30 AM

Clarity Clinic, a leading provider of mental health services in Illinois, is expanding its Partial Hospitalization (PHP) and Intensive Outpatient (IOP) programs to its Evanston location to better serve individuals struggling with depression, anxiety, and other mood-related disorders in the northern suburbs. Following the success of its PHP/IOP program at the Chicago Loop location, Clarity Clinic is making its comprehensive mental health programs...

Read more

Harvard-Trained Facial Plastic Surgeon Dr. Yamasaki Highlights Techniques for Skin Cancer Reconstruction on the Face

February 6, 2025 9:00 AM

Dr. Alisa Yamasaki, a renowned Harvard-trained facial plastic and reconstructive surgeon, is bringing her expertise to the forefront in the critical area of skin cancer reconstruction on the face. With a commitment to providing natural-looking and restorative results, Dr. Yamasaki is empowering patients who have undergone Mohs surgery or other procedures for skin cancer treatment. Her approach emphasizes precision, compassion, and...

Read more

Alter Behavioral Health Opens New Residential Mental Health Facility in Dana Point, California

February 6, 2025 9:00 AM

Alter Behavioral Health has opened a new residential mental health center in Dana Point. This is a big step for Alter, which wants to give everyone top-notch care in a space made for healing. This new place sits right by the beautiful Dana Point coast. Here, patients will relax and start feeling better with the help of smart mental health therapies. It's a perfect location for those who need extra support."This opening is a big deal for us,"...

Read more

Avante Health Solutions Announces Successful Completion of Sale to Staple Street Capital

February 6, 2025 8:30 AM

Avante Health Solutions ("Avante" or "the Company"), a leading provider of aftermarket parts, service, repair, and refurbishment for medical equipment, is excited to announce that it has successfully exited bankruptcy and has been recapitalized with a debt-free balance sheet by an affiliate of Staple Street Capital Group, LLC, a private equity firm that specializes in investing in market‐leading businesses where there are transformational...

Read more